Formosa Pharmaceuticals, Inc.
Formosa Pharmaceuticals, Inc., commonly referred to as Formosa Pharma, is a leading biopharmaceutical company headquartered in Taiwan (TW). Established in 2015, the company has rapidly positioned itself within the global pharmaceutical landscape, focusing on the development of innovative therapies for unmet medical needs, particularly in oncology and autoimmune diseases. With a robust pipeline of proprietary products, Formosa Pharma distinguishes itself through its commitment to advanced drug delivery systems and targeted therapies. The company has achieved significant milestones, including successful clinical trials and strategic partnerships that enhance its market presence. Renowned for its dedication to research and development, Formosa Pharmaceuticals continues to make strides in improving patient outcomes and solidifying its reputation as a key player in the biopharmaceutical industry.
DitchCarbon Score
How does Formosa Pharmaceuticals, Inc.'s carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Formosa Pharmaceuticals, Inc.'s score of 22 is lower than 83% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Formosa Pharmaceuticals, Inc.'s reported carbon emissions
Formosa Pharmaceuticals, Inc., headquartered in Taiwan (TW), currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges from the company, suggesting a lack of formal commitments to address carbon emissions at this time. As there is no inherited emissions data from a parent company or related organisation, all information regarding emissions and climate initiatives is based solely on Formosa Pharmaceuticals, Inc.'s own disclosures. The absence of emissions data and reduction initiatives places the company in a context where it may need to enhance its climate strategy to align with industry standards and expectations for sustainability.
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Formosa Pharmaceuticals, Inc. is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
